Heartflow, Inc. (HTFL) intrinsic value & 10-year financials

Heartflow, Inc. (HTFL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue grew 42.1% a year to $176.0M, with an average return on invested capital of 12.5%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$48.29
Market cap
$1.8B
Revenue (FY2025)
$176.0M
Revenue growth (4-yr CAGR)
42.1%
ROIC (10-yr avg)
12.5%
Free cash flow (FY2025)
-$59.0M

HTFL 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $176.0M -$116.8M -$3.17 -$59.0M -36.4% 20.6%
FY2024 $125.8M -$96.4M -$2.57 -$73.4M -48.7% 6.9%
FY2023 $87.2M -$95.7M -$3.62 -$82.5M -83.6% 9.9%
FY2022 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Heartflow, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Heartflow, Inc. returns on capital have been average, hovering around 12.5% ROIC over the decade.

Heartflow, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Heartflow, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-105.29 per share.

HTFL stock: frequently asked questions

What is the intrinsic value of Heartflow, Inc. (HTFL) stock?

Graham's formula only works with positive earnings. Heartflow, Inc. reported diluted EPS of -$3.17 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Heartflow, Inc. generate free cash flow?

Heartflow, Inc. generated -$59.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 3 reported years.

What is HTFL's return on invested capital?

Average ROIC over the last 4 fiscal years was 12.5%, and average return on equity was 22.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this HTFL data come from?

From Heartflow, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks